Thank you for joining us for Eli Lilly & Company's Q1 2025 earnings call ... and of course our self-pay effort with vials as well. Hi, guys. Thank you so much for taking my question.

“Clown in a Cornfield” (RLJ Entertainment): This slasher from director Eli Craig (“Tucker & Dale vs. Evil”) features a killer named Frendo. “Lilly” (Blue Harbor Entertainment, theaters ...

Eli Lilly and Company became the first tenant to move into Lebanon’s LEAP district during a groundbreaking ceremony on ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other growth stocks to buy for the next 3 years. On April 29, Dan Ives of Wedbush Securities ...

Eli Lilly's Q1 numbers showed strong revenue and earnings growth, driven by its GLP-1 offerings. The company's 2025 outlook disappointed investors, however, leading to the decline. The stock ...

CompanyOverview|NYSE:LLY] The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), recently had its worst ...

Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...

Big move on Thursday as investors in Eli Lilly and Company (LLY) endured an almost 12% downside as investors consider the aftermath of the CVS formulary decision changes that impacted the ...

Eli Lilly (LLY) has enjoyed a successful run the past several quarters as the company's blockbuster GLP-1 weight-loss drug Wegovy gains steam in the obesity space. Wegovy was first to market but ...

Eli Lilly still lags behind Novo Nordisk in the diabetes space, with Ozempic accounting for 43% of the market share while Mounjaro takes 39%, based on IQVIA data. The company has been ramping up ...

The company maintained its fiscal 2025 sales guidance of $58 billion to $61 billion. Eli Lilly said the guidance reflects President Donald Trump's existing tariffs as of May 1, but does not ...